Comera Life Sciences Holdings, Inc. (CMRA)
| Market Cap | 9.77M |
| Revenue (ttm) | 319,832 |
| Net Income (ttm) | -5.45M |
| Shares Out | 3.91M |
| EPS (ttm) | 0.17 |
| PE Ratio | 14.53 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 828,908 |
| Open | 2.50 |
| Previous Close | 3.39 |
| Day's Range | 2.50 - 3.08 |
| 52-Week Range | 2.50 - 11.44 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CMRA
As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.
Financial Performance
In 2021, CMRA's revenue was $319,832, a decrease of -27.79% compared to the previous year's $442,919. Losses were -$5.45 million, 156.5% more than in 2020.
Financial StatementsNews
What's Going On With OTR Acquisition Stock Today?
OTR Acquisition Corp (NASDAQ: OTRA) shares are trading higher Wednesday after the company filed a Form 8-K with the U.S. Securities and Exchange Commision. The move appears to be related to the high num...
Why Is OTR Acquisition (OTRA) Stock Up Today?
The shares of OTR Acquisition are climbing after the SPAC's shareholders overwhelmingly approved a merger with Comera. The post Why Is OTR Acquisition (OTRA) Stock Up Today?
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Form...
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and c...
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced ...
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
WOBURN, Mass. & AHMEDABAD, India--(BUSINESS WIRE)--Today, Comera Life Sciences, Inc. (“Comera” or the “Company”) and Intas Pharmaceuticals Ltd. (“Intas”) announced a research collaboration to develop a ...
Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business...
WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenienc...